Use of an investigational monoclonal antibody called bimagrumab added to semaglutide produced weight loss while preserving ...

These patient testimonials helped push metreleptin over the line into approval, and the drug was finally approved for routine use on the NHS in January 2021.

The primary endpoint, percentage-point change in A1c from baseline to week 40, showed reductions of 1.24, 1.47, 1.48 for the 3-mg, 12-mg, and 36-mg doses, respectively, compared with a 0.41 ...

Learn about Acquired Lipodystrophy, its causes, symptoms, types (AGL, APL), and treatments, including metabolic management and cosmetic options. Read more ...

Browse the complete list of all our published health and social care guidance, including guidelines, NICE advice and quality standards ...

Type Type Guidance (1259) NICE advice (214) Quality standard (132) ...

1 Introduction Fourman et al. have recently published a clinically-oriented rapid action plan for the diagnosis and management of lipodystrophy syndromes (1). Lipodystrophy syndromes may be ...

Introduction: Lipodystrophy syndromes comprise a group of rare endocrine disorders characterized by the generalized or partial loss of adipose tissue. Affected individuals frequently display absolute ...